Want to see SE:QCORE full AI Analyst Report?
Top Page
Qlucore AB
(QCORE)
Select Model
Select Model
Rating:44Neutral
Price Target:
kr0.32
▼(-36.00% Downside)
Action:Reiterated
Date:09/29/26
The score is driven primarily by weak financial performance—especially severely negative profitability and ongoing cash burn—partly offset by low leverage on the balance sheet. Technicals add a modest headwind with price below key moving averages and negative MACD, while valuation is neutral-to-weak due to a negative P/E and no dividend yield data.
Positive Factors
Low leverage
Very low leverage reduces refinancing and solvency pressure, giving Qlucore more flexibility to manage its operations and allocate capital. Declining debt also limits fixed financial obligations, although this benefit depends on the company addressing its ongoing operating losses.
Negative Factors
Severely negative profitability
Gross profit below zero indicates that reported sales are not currently covering the cost of revenue, while large operating and net losses show pressure beyond the core delivery economics. This weak profitability threatens the sustainability of the software model unless costs improve materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Very low leverage reduces refinancing and solvency pressure, giving Qlucore more flexibility to manage its operations and allocate capital. Declining debt also limits fixed financial obligations, although this benefit depends on the company addressing its ongoing operating losses.
Read all positive factors
Qlucore AB (QCORE) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr15.57M
Dividend YieldN/A
Average Volume (3M)16.51K
Price to Earnings (P/E)―
Beta (1Y)0.14
Revenue Growth-18.34%
EPS Growth59.68%
CountrySE
Employees12
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Application
Share Statistics
EPS (TTM)-1.01
Shares Outstanding42,900,500
10 Day Avg. Volume16,567
30 Day Avg. Volume16,507
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.38
Price to Sales (P/S)2.07
P/FCF Ratio-1.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Qlucore AB Business Overview & Revenue Model
Company Description
Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bio...
How the Company Makes Money
Qlucore AB generates revenue primarily by selling access to its software products, mainly Qlucore Omics Explorer. The core revenue stream is software licensing/subscriptions (exact mix of license types, pricing structure, and contract duration: nu...
Qlucore AB Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.57M | 6.74M | 10.21M | 14.37M | 12.67M | 14.12M |
| Gross Profit | -16.95M | -20.51M | -9.75M | 7.40M | 5.80M | 5.43M |
| EBITDA | -32.05M | -20.43M | -15.44M | -11.27M | -11.86M | -7.99M |
| Net Income | -32.77M | -36.52M | -20.54M | -15.68M | -15.94M | -11.66M |
Balance Sheet | ||||||
| Total Assets | 42.74M | 42.01M | 69.95M | 90.01M | 109.36M | 121.90M |
| Cash, Cash Equivalents and Short-Term Investments | 6.06M | 2.97M | 5.26M | 28.62M | 69.73M | 97.97M |
| Total Debt | 1.25M | 1.40M | 2.00M | 3.18M | 4.46M | 5.33M |
| Total Liabilities | 9.28M | 5.71M | 11.49M | 10.90M | 14.63M | 11.34M |
| Stockholders Equity | 33.47M | 36.30M | 58.47M | 79.11M | 94.73M | 110.56M |
Cash Flow | ||||||
| Free Cash Flow | -13.84M | -12.51M | -22.38M | -39.47M | -27.06M | -15.76M |
| Operating Cash Flow | -10.30M | -12.46M | -14.15M | -16.95M | -8.05M | -6.81M |
| Investing Cash Flow | -3.54M | -3.67M | -8.22M | -22.52M | -19.02M | -8.95M |
| Financing Cash Flow | 13.79M | 13.79M | -1.18M | -1.27M | -808.00K | 86.25M |
Qlucore AB Technical Analysis
Negative
0.50
Price Trends
0.39
Negative
0.39
Negative
0.41
Negative
Market Momentum
-0.01
Positive
34.50
Neutral
40.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:QCORE, the sentiment is Negative. The current price of 0.5 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.39, and above the 200-day MA of 0.41, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 34.50 is Neutral, neither overbought nor oversold. The STOCH value of 40.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:QCORE.
Qlucore AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | kr10.59B | 22.89 | 9.37% | 1.36% | 5.39% | 16.79% | |
65 Neutral | kr1.74B | 41.93 | ― | 15.83% | ― | ― | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | kr145.80M | -7.09 | -71.49% | ― | -21.53% | 64.53% | |
45 Neutral | kr133.80M | -1.85 | -18.04% | ― | -19.38% | -78.61% | |
44 Neutral | kr15.57M | -0.33 | ― | ― | -18.34% | 59.68% | |
41 Neutral | kr67.05M | -0.27 | -27.63% | ― | ― | ― |
* General Sector Average
SE:QCORE
Qlucore AB
0.33
-0.15
-31.25%
SE:PREC
Precise Biometrics AB
0.50
-1.96
-79.72%
SE:SUBGEN
AegirBio AB
0.03
-10.57
-99.72%
SE:MODEL
Modelon AB
8.30
-4.00
-32.52%
SE:VIT.B
Vitec Software Group AB Class B
267.80
-87.01
-24.52%
SE:CARA
Carasent AB
26.10
0.20
0.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.